An examination of the private biotech industry reveals shrinking financial resources and higher hurdles to obtain funding, but new models are evolving to meet the challenge.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Supplementary information
Supplementary Text and Figures
Supplementary Figure 1 and Supplementary Tables 1-8 (XLSX 63 kb)
Rights and permissions
About this article
Cite this article
Huggett, B. Biotech's wellspring: a survey of the health of the private sector. Nat Biotechnol 30, 395–400 (2012). https://doi.org/10.1038/nbt.2209
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.2209
This article is cited by
-
Publications and patents in corporate venture–backed biotech
Nature Biotechnology (2013)
-
Biotech's wellspring: the health of private biotech in 2012
Nature Biotechnology (2013)
-
The changing face of corporate venturing in biotechnology
Bioentrepreneur (2012)
-
Social networks attempt to spark academic–industry collaborations
Nature Biotechnology (2012)
-
Can biotech spur job creation?
Nature Biotechnology (2012)